Publications by authors named "David G Frame"

Claim this Profile
P
PD-1 inhibition for relapse after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome.
John M Magenau, David G Frame, Mary Riwes, John Maciejewski, Sarah Anand

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin's lymphoma.
David G Frame, Marcus Geer, Salena Kasha, Denise Markstrom, Gianni Scappaticci

Front Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal plasma proteomics in CAR T-cell therapy patients implicates neutrophils and NETosis in the genesis of CRS.
Christopher Flora, Mary Olesnavich, Yu Zuo, Erin Sandford, Rashmi Madhukar, David G Frame

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjustments to pharmacologic therapies for hemophagocytic lymphohistiocytosis while on extracorporeal support.
Angela C Weyand, Ryan P Barbaro, Kelly J Walkovich, David G Frame

Pediatr Blood Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-γ Receptor 1 Deficiency Corrected by Umbilical Cord Blood Transplantation.
Thomas F Michniacki, Kelly J Walkovich, David G Frame, Mark T Vander Lugt

J Clin Immunol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure.
Thomas F Michniacki, Mark Hannibal, Charles W Ross, David G Frame, Adam S DuVall

J Clin Immunol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients.
Bernard Lawrence Marini, Sung Won Choi, Craig Alan Byersdorfer, Simon Cronin, David G Frame

Biol Blood Marrow Transplant· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?
Bernard L Marini, Anthony J Perissinotti, Angela M Huang, David G Frame, Daniel R Kaul

Antimicrob Agents Chemother· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practice management of CINV in oncology patients: I. Physiology and treatment of CINV. Multiple neurotransmitters and receptors and the need for combination therapeutic approaches.
David G Frame

J Support Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis